Integrated Evidence Planning (IEP) enables pharma companies to address the evolving evidence needs of different external stakeholders throughout a product’s lifecycle. Effective IEP relies on a cross-functional team that owns the integrated evidence plan, to drive the delivery of compelling evidence generation and successfully influence decision-making by patients, physicians, and payers.
Read the full one-page article summarising best practices in IEP by clicking the button above.
